What is the purpose of this trial?Children are highly sensitive to adversity during their first five years of life, with exposure to chronic parental mental illness (MI) consistently linked to socio-emotional impairments and mental health problems in children. Children born during the COVID-19 pandemic were exposed to unprecedented level of parental distress, with parental MI reported at three times the pre-pandemic rates. This situation underscored a pressing need for scalable solutions to foster positive mental health and developmental outcomes for a generation of children. In response, the investigators developed the Building Emotional Awareness and Mental Health (BEAM) program, an innovative mobile health (mHealth) solution for parents of young children. Clinical trials to date evaluating BEAM have shown promising results, demonstrating reductions in parent depression, anxiety, and harsh parenting practices. This trial involves an effectiveness-implementation hybrid design with co-primary aims of (1) determining BEAM's effectiveness in improving child mental health and developmental outcomes, and (2) evaluating the implementation of BEAM in the community through metrics such as feasibility, acceptability, and uptake. The secondary aim of this trial is to measure BEAM's effectiveness in improving long-term biopsychosocial family outcomes using administrative data. A final exploratory aim of this trial will measure the cost-utility of delivering BEAM relative to extant health programming.
This trial will evaluate the effectiveness of implementing the BEAM intervention in the community with a sample of 400 parent participants with a child aged 24-71 months. Study participants will complete 12 weeks of psychoeducation modules in the BEAM app, with access to an online social support forum and check ins with a peer coach. Assessments of parent and child symptoms will occur at pre-test before BEAM begins (T1), immediately after the last week of the BEAM intervention (post-test, T2), 6-month follow-up (T3), and 12-month follow-up (T4).
The BEAM program offers a promising solution to addressing elevated parental mental health symptoms, parenting stress, and related child functioning concerns. The present implementation trial aims to extend the groundwork established by an open pilot trial and RCT of the BEAM program, in a next step of testing BEAM's readiness for nationwide scaling.
Will I have to stop taking my current medications?The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, especially since the trial focuses on a mobile health program rather than medication changes.
What data supports the effectiveness of the BEAM Program for Parental Mental Health treatment?Research on similar emotional awareness-based parenting programs shows promising results, with participants experiencing reduced stress and improved emotional awareness. Additionally, emotion-focused family therapy has been effective in helping parents resolve emotional issues and gain confidence in supporting their children's mental health.
12345 How is the BEAM treatment different from other treatments for parental mental health?The BEAM program is unique because it is an app-based treatment that simultaneously targets both maternal mental health and parenting skills, addressing the gap where most programs focus on one or the other. It is designed to be accessible and mitigate the impacts of pandemic stress on family well-being, making it particularly relevant during times when traditional services are limited.
678910